GemVax & KAEL Co.,Ltd.
Clinical-stage biopharma developing therapeutics for neurodegenerative diseases.
082270 | KO
Overview
Corporate Details
- ISIN(s):
- KR7082270000
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 테크노11로 58, 대전광역시
- Website:
- https://gemvax.com/
- Sector:
- Manufacturing
Description
GemVax & KAEL is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics. Its lead drug candidate is GV1001, a synthetic peptide composed of 16 amino acids, which has demonstrated multiple actions including the modulation of neuroinflammation and reduction of oxidative stress. The company's development pipeline primarily targets neurodegenerative diseases, such as Alzheimer's disease and Progressive Supranuclear Palsy (PSP). Other therapeutic areas under investigation include pancreatic cancer and benign prostatic hyperplasia. GemVax & KAEL is actively advancing its programs through clinical trials to evaluate the efficacy and safety of its novel treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-07-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 168.7 KB | ||
| 2023-07-19 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 57.6 KB | ||
| 2023-07-14 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2023-07-13 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 55.3 KB | ||
| 2023-07-11 00:00 |
투자판단관련주요경영사항(임상시험계획승인신청)(진행성 핵상마비 치료제로서 GV1001의 국내 2상 임상시험에 대한 연장 임상시험계획(IND) 신…
|
Korean | 9.5 KB | ||
| 2023-07-10 00:00 |
기업설명회(IR)개최
|
Korean | 6.8 KB | ||
| 2023-07-07 00:00 |
투자판단관련주요경영사항(임상시험결과)(양성전립선비대증(BPH) 치료제 GV1001의 한국 식약처 제3상 임상시험 결과)
|
Korean | 12.5 KB | ||
| 2023-07-03 00:00 |
기타경영사항(자율공시)(소규모 합병 승인 이사회(주주총회 갈음) 결과 보고)
|
Korean | 8.3 KB | ||
| 2023-06-23 00:00 |
[기재정정]주식등의대량보유상황보고서(일반)
|
Korean | 169.8 KB | ||
| 2023-06-21 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 56.8 KB | ||
| 2023-06-20 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 155.6 KB | ||
| 2023-06-13 00:00 |
[기재정정]최대주주변경을수반하는주식담보제공계약체결
|
Korean | 55.4 KB | ||
| 2023-06-07 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 155.7 KB | ||
| 2023-06-01 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.5 KB | ||
| 2023-06-01 00:00 |
[첨부추가]주요사항보고서(회사합병결정)
|
Korean | 69.0 KB |
Automate Your Workflow. Get a real-time feed of all GemVax & KAEL Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GemVax & KAEL Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GemVax & KAEL Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
